World's Best Scientists 2026 revealed!
Riccardo Lencioni

Riccardo Lencioni

D-Index & Metrics

Medicine

D-Index
89
Citations
58088
World Ranking
12411
National Ranking
469

Riccardo Lencioni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Riccardo Lencioni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 409 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Riccardo Lencioni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Riccardo Lencioni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Riccardo Lencioni is affiliated with the University of Pisa in Italy and has contributed extensively to research in the field of medicine, with a particular focus on hepatology. Their work spans various subfields including radiology, nuclear medicine, imaging, pulmonary and respiratory medicine, cardiology and cardiovascular medicine, as well as oncology.

The scientist has published a significant number of papers dealing with hepatocellular carcinoma treatment and prognosis, lung cancer treatments and mutations, colorectal cancer studies, cancer mechanisms and therapy, cardiomyopathy and myosin studies, renal cell carcinoma treatment, and liver disease diagnosis and treatment.

Recent notable publications by Riccardo Lencioni include:

  • EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization, 2024, Journal of Clinical Oncology

While many frequently cited papers in the domain of hepatocellular carcinoma are authored by Josep M. Llovet, they reflect the core scientific conversations within the same field in which Lencioni has contributed. Some important papers related to this subject include:

  • Hepatocellular carcinoma, 2021, Nature Reviews Disease Primers
  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma, 2021, Nature Reviews Gastroenterology & Hepatology
  • mRECIST for HCC: Performance and novel refinements, 2020, Journal of Hepatology
  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference, 2020, Hepatology

Riccardo Lencioni has collaborated frequently with a number of researchers, including:

  • Masatoshi Kudo
  • Dania Cioni
  • Emanuele Neri
  • Richard S. Finn
  • Bruno Sangro

The scientist's publications are often found in specific medical and oncological journals, with multiple works in the following venues:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Journal of Hepatology
  • Diagnostics
  • Journal of Vascular and Interventional Radiology

Lencioni's research predominantly addresses issues related to the diagnosis and treatment of liver cancer and related diseases, integrating imaging techniques and molecular therapies. Their work contributes to the understanding of cancer mechanisms and therapeutic approaches in hepatology and oncology broadly.

Best Publications

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

    Riccardo Antonio Lencioni;Jm Llovet;Jm Llovet

  • Hepatocellular carcinoma.

    Josep M Llovet;Robin Kate Kelley;Augusto Villanueva;Amit G Singal

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

    Johannes Lammer;Katarina Malagari;Thomas Vogl;Frank Pilleul

  • Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

    Riccardo A. Lencioni;Hans Peter Allgaier;Dania Cioni;Manfred Olschewski

  • Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update

    Muneeb Ahmed;Luigi Solbiati;Christopher L. Brace;David J. Breen

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

    M. Claudon;D. Cosgrove;T. Albrecht;L. Bolondi

  • Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation

    Riccardo Lencioni;Dania Cioni;Laura Crocetti;Chiara Franchini

  • Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

    Jeong Heo;Tony Reid;Leyo Ruo;Caroline J. Breitbach

  • Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

    T Albrecht;M Blomley;L Bolondi;M Claudon

  • Local-Regional Treatment of Hepatocellular Carcinoma

    Riccardo Antonio Lencioni;Laura Crocetti

  • Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.

    Sandro Rossi;Francesco Garbagnati;Riccardo Lencioni;Hans-Peter Allgaier

  • Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

    Riccardo Lencioni;Josep M. Llovet;Guohong Han;Won Young Tak

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

    Riccardo Lencioni;Thierry de Baere;Michael C. Soulen;William S. Rilling

  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Thierry De Baere;Thierry De Baere;Laura Kulik;Philipp K. Haber

  • Loco-regional treatment of hepatocellular carcinoma.

    Riccardo Lencioni

  • The Etiology of Hepatocellular Carcinoma and Consequences for Treatment

    Arun J. Sanyal;Seung Kew Yoon;Riccardo Lencioni

  • Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)

    Riccardo Lencioni;Laura Crocetti;Roberto Cioni;Robert Suh

Frequent Co-Authors

Masatoshi Kudo
Masatoshi Kudo Kindai University
Thomas J. Vogl
Thomas J. Vogl Goethe University Frankfurt
Josep M. Llovet
Josep M. Llovet University of Barcelona
Alan P. Venook
Alan P. Venook University of California, San Francisco
Johannes Lammer
Johannes Lammer Medical University of Vienna
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Tadatoshi Takayama
Tadatoshi Takayama Nihon University
Thierry de Baere
Thierry de Baere Institut Gustave Roussy
Luigi Bolondi
Luigi Bolondi University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean becoming a doctor. The healthcare field offers many alternative paths, some of which can be pursued online. For those interested in leadership and organizational roles within hospitals or healthcare facilities, healthcare administration programs provide strong management foundations and can lead to roles in hospital management or health services administration.

Nurses looking to advance their clinical expertise can consider adn to fnp programs, which offer efficient pathways from an associate degree in nursing to a family nurse practitioner credential.

For those passionate about diet, wellness, and supporting public health, earning an online degree nutrition can open doors to roles in dietetics, nutrition counseling, or health education.

Accreditation is especially important in healthcare education. If you’re considering a master’s-level qualification, it’s worth exploring which online healthcare degree programs are recognized for their accreditation by cahme? Accredited programs help ensure your degree meets rigorous industry standards, boosting employability.

Best Scientists Citing Riccardo Lencioni

Trending Scientists

Recently Published Articles